Clinical Trial Update: Efficacy of Quetiapine XR Versus Placebo as Concomitant Treatment to Mood Stabilizers in the Control of Subsyndromal Symptoms of Bipolar Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluated quetiapine XR as an adjunct to mood stabilizers for controlling subsyndromal symptoms in bipolar disorder; the study has completed and r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Quetiapine XR (quetiapine)

Snippet

Sponsor: Centro de Investigación Biomédica en Red de Salud Mental | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED